Cargando…
Commentary on Glanz et al.: Longer buprenorphine treatment duration is associated with lower rates of opioid overdose, but can we address barriers to staying in treatment?
Autores principales: | Nielsen, Suzanne, Larney, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086851/ https://www.ncbi.nlm.nih.gov/pubmed/36045583 http://dx.doi.org/10.1111/add.16032 |
Ejemplares similares
-
Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022) -
Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone
por: Kline, Anna, et al.
Publicado: (2023) -
Glanz und untergang des alten Mexiko : die azteken und ihre vorläufer [1] /
Publicado: (1986) -
Glanz und untergang des alten Mexiko : die azteken und ihre vorläufer [2] /
Publicado: (1986) -
The impact of opioid agonist treatment on fatal and non-fatal drug overdose among people with a history of opioid dependence in NSW, Australia, 2001-2018: findings from the OATS retrospective linkage study.
por: Jones, Nicola, et al.
Publicado: (2022)